Literature DB >> 31200592

Correction: Klingler, M., et al. Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m. Pharmaceuticals 2019, 12, 13.

Maximilian Klingler1, Christine Rangger2, Dominik Summer3, Piriya Kaeopookum4, Clemens Decristoforo5, Elisabeth von Guggenberg6.   

Abstract

In our paper [...].

Entities:  

Year:  2019        PMID： 31200592      PMCID： PMC6631989          DOI： 10.3390/ph12020088

Source DB:  PubMed          Journal:  Pharmaceuticals (Basel)        ISSN： 1424-8247


In our paper [1], an error unfortunately occurred in Figure 1. We therefore would like to provide the readers with the corrected figure and apologize for this inconvenience.
Figure 1

Amino acid sequence and chemical structure of (a) HYNIC-MGS5 and (b) HYNIC-MGS11.

  1 in total

1.  Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m.

Authors:  Maximilian Klingler; Christine Rangger; Dominik Summer; Piriya Kaeopookum; Clemens Decristoforo; Elisabeth von Guggenberg
Journal:  Pharmaceuticals (Basel)       Date:  2019-01-15
  1 in total
  1 in total

Review 1.  Cholecystokinin-2 Receptor Targeting with Radiolabeled Peptides: Current Status and Future Directions.

Authors:  Maximilian Klingler; Anton Amadeus Hörmann; Elisabeth Von Guggenberg
Journal:  Curr Med Chem       Date:  2020       Impact factor: 4.530
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.